Fidelity Disruptive Medicine ETF (FMED)

Assets	$60.67M
Expense Ratio	0.50%
PE Ratio	41.38
Shares Out	2.32M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	6,481
Open	26.13
Previous Close	26.27
Day's Range	25.98 - 26.28
52-Week Low	20.69
52-Week High	29.07
Beta	1.00
Holdings	73
Inception Date	Apr 16, 2020

About FMED

Fund Home Page

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: FMED
• ETF Provider: Fidelity

Top 10 Holdings

44.65% of assets

Name	Symbol	Weight
Fidelity Securities Lending Cash Central Fund	n/a	11.84%
UCB SA	UCB	4.53%
Danaher Corporation	DHR	4.25%
argenx SE	ARGX	4.24%
Boston Scientific Corporation	BSX	3.97%
Cogent Biosciences, Inc.	COGT	3.77%
Alnylam Pharmaceuticals, Inc.	ALNY	3.37%
Intuitive Surgical, Inc.	ISRG	3.11%
Veeva Systems Inc.	VEEV	2.99%
Insulet Corporation	PODD	2.60%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 20, 2024	$0.112	Dec 24, 2024
Jun 21, 2024	$0.001	Jun 25, 2024

Performance

FMED had a total return of -0.11% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.60%.